No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Northwell Appoints 2 Physician Leaders: David Battinelli, MD & Jill Kalman, MD

Drs. David Battinelli, Jill Kalman assume new senior leadership roles at New York State’s largest health system

Editor: What To Know

  • “To keep pace with Northwell's ongoing growth and expansion, it's vital that we evolve the roles and responsibilities of our clinical leaders so we can continue to fulfill our mission to improve the health of the communities we serve by providing the highest quality clinical care and strengthening the education of current and future generations of health care professionals,” said Michael Dowling, president and CEO of Northwell Health.
  • Northwell Health today announced the appointment of David Battinelli, MD, as executive vice president and physician-in-chief, 14 years after joining the health system first as chief academic officer and then as senior vice president and chief medical officer and vice dean of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell.
  • Smith's invaluable leadership enabled us to create one of the nation's most-innovative medical schools, strengthen and expanded our graduate medical education programs, and significantly enhance Northwell's ability to attract medical students, residents and strong academic physician leaders,” said Kathleen Gallo, RN, PhD,  Executive Vice President and Chief Learning Officer at Northwell Health and Dean of the Hofstra/ Northwell School of Nursing and Physician Assistant Studies.

Northwell Health today announced the appointment of David Battinelli, MD, as executive vice president and physician-in-chief, 14 years after joining the health system first as chief academic officer and then as senior vice president and chief medical officer and vice dean of the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He succeeds Lawrence G. Smith, MD, MACP, who will continue to serve as the founding dean of the Zucker School of Medicine.

Jill Kalman, MD

In addition, Jill Kalman, MD, has been appointed senior vice president, chief medical officer and deputy physician-in-chief. Dr. Kalman served as Lenox Hill Hospital’s executive director for three years before pursuing another opportunity in early 2021.  Her return bolsters an already strong senior clinical leadership team at Northwell Health, the largest health system and private employer in New York State.

“To keep pace with Northwell’s ongoing growth and expansion, it’s vital that we evolve the roles and responsibilities of our clinical leaders so we can continue to fulfill our mission to improve the health of the communities we serve by providing the highest quality clinical care and strengthening the education of current and future generations of health care professionals,” said Michael Dowling, president and CEO of Northwell Health. “Over many years at Northwell, the exceptional contributions of these three highly skilled leaders have helped elevate Northwell’s clinical, academic and research reputation, enabling us to attract the best and brightest talent. I’m confident they will guide us toward even greater success in the years ahead.”

While Dr. Kalman assumes her role immediately, Dr. Battinelli will become physician-in-chief, effective January 1, 2022 and dean of Zucker School of Medicine at Hofstra/Northwell for the incoming class in August.  Dr. Battinelli played a key role in the health system’s COVID-19 response, and is responsible for the overall professional management of clinical, education, research and operational issues related to medical and clinical affairs. Dr. Kalman successfully led the Lenox Hill response to the COVID-19 pandemic and its recovery efforts. She was instrumental in expanding programs during her tenure at Lenox Hill and saw the hospital earn Magnet status, the highest honor representing nursing excellence. Under her tenure, the hospital achieved a 91 percentile ranking in the most recent workforce engagement survey.

Dr. Smith joined Northwell in May 2005 as chief academic officer and senior vice president of academic affairs. His leadership transformed the health system and was the driving force in the creation of the Zucker School of Medicine, which welcomed its first class in 2011 – becoming New York State’s first new allopathic medical school in 40 years.

“Over the past 16 years, Dr. Smith’s invaluable leadership enabled us to create one of the nation’s most-innovative medical schools, strengthen and expanded our graduate medical education programs, and significantly enhance Northwell’s ability to attract medical students, residents and strong academic physician leaders,” said Kathleen Gallo, RN, PhD,  Executive Vice President and Chief Learning Officer at Northwell Health and Dean of the Hofstra/ Northwell School of Nursing and Physician Assistant Studies.

With 77,000 employees, 23 hospitals and 830 outpatient facilities throughout the New York area, Northwell has treated more than 225,000 COVID patients – more than any other health system in New York State – and vaccinated hundreds of thousands of New Yorkers.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy